• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ATX
Click for more information
6.56% 6.5¢

AMPLIA THERAPEUTICS LIMITED

Market Cap $16.56M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Biotechnology

Amplia Therapeutics Limited is an Australia-based clinical-stage, drug development... Amplia Therapeutics Limited is an Australia-based clinical-stage, drug development company. The Company is focused on developing proprietary, orally available, small molecule Focal Adhesion Kinase (FAK) inhibitors as candidate drugs for the treatment of cancer and various fibrotic diseases. The Company's pipeline includes narmafotinib (AMP945) and AMP886. narmafotinib is a selective and potent inhibitor of FAK and is in clinical development for pancreatic cancer and advanced preclinical development for idiopathic pulmonary fibrosis (IPF). The Company's second pipeline drug, AMP886, inhibits FAK and inhibits two key disease drug targets (VEGFR3 and FLT3). This drug is being evaluated in preclinical models of cancer. Its fibrosis program uses its FAK inhibitors to block fibrosis and cell migration in cancers. Its cancer Program is directed at using its FAK inhibitors to block FAK activity in the cancer cells and the surrounding tissue and therefore block survival/proliferation signals.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
ATX
Ann: First 26 Patients recruited in Phase 2A ACCENT Trial 		10:24 2 244
10:24 Last post  Meledath Comments Created with Sketch.  2  Views Created with Sketch.  244 
ATX
Ann: Annual General Meeting to be held Friday 23 August 2024 		02/07/24 0 122
02/07/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  122 
ATX
Ann: Notification of cessation of securities - ATX 		25/06/24 0 191
25/06/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  191 
ATX
Ann: Change of Director's Interest Notice - Dr Robert Peach 		21/06/24 2 784
21/06/24 Last post  revolution Comments Created with Sketch.  2  Views Created with Sketch.  784 
ATX
Ann: Presentation and Webinar 		21/06/24 12 3.8K
21/06/24 Last post  Eclectic_nish Comments Created with Sketch.  12  Views Created with Sketch.  3.8K 
ATX
Ann: Amplia Establishes World Class Clinical Advisory Board 		06/06/24 10 2.5K
06/06/24 Last post  Eclectic_nish Comments Created with Sketch.  10  Views Created with Sketch.  2.5K 
ATX
Ann: Preliminary Final Report and Annual Report YE 31 March 2024 		02/06/24 5 1.5K
02/06/24 Last post  leveller Comments Created with Sketch.  5  Views Created with Sketch.  1.5K 
ATX
Ann: Appendix 4G - Key to Corporate Governance Disclosures 		30/05/24 0 176
30/05/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  176 

See All Discussions arrow Created with Sketch.

Timeline

First 26 Patients recruited in Phase 2A ACCENT Trial
03 Jul 09:54
 
Annual General Meeting to be held Friday 23 August 2024
02 Jul 17:38
 
Notification of cessation of securities - ATX
25 Jun 16:14
 
Change of Director's Interest Notice - Dr Robert Peach
20 Jun 16:11
 
Presentation and Webinar
11 Jun 10:30
 
Amplia Establishes World Class Clinical Advisory Board
03 Jun 08:33
 
View More arrow Created with Sketch.

Featured News

LLL Leo Lithium announces major divestment of flagship Goulamina project to Ganfeng
right-arrow Created with Sketch.
AVA Ava Risk Group expands US presence with A$0.7M Substation Deal
right-arrow Created with Sketch.
BIO Biome posts record sales revenue of $13M in FY24 – up 80% vs pcp and higher than forecast
right-arrow Created with Sketch.
EX1 Tryptamine Therapeutics completes maiden dosing of IV psilocin – a global first
right-arrow Created with Sketch.
NEWS Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom
right-arrow Created with Sketch.
ITM iTech lifts MRE at Eyre Peninsula Graphite Project by 300%
right-arrow Created with Sketch.

Latest Videos

Amplia Therapeutics mints $2.4m R&D tax benefit


20 Oct 2023 10:46 (AEDT)

(20min delay)
Last
6.5¢ 		Change
0.004(6.56%) 		Mkt cap ! $16.56M
Open High Low Value Volume
6.2¢ 6.5¢ 6.1¢ $17.05K 267.5K

Buyers (Bids)

No. Vol. Price($)
2 185000 6.2¢
 

Sellers (Offers)

Price($) Vol. No.
6.5¢ 11666 1
View Market Depth
Last trade - 11.07am 03/07/2024 (20 minute delay) ?
Last
6.2¢ 		  Change
0.004 ( 0.00 %)
Open High Low Volume
6.2¢ 6.3¢ 6.2¢ 128096
Last updated 11.30am 03/07/2024 ?
ATX (ASX) Chart

Top Stories

Has uranium run out of steam? An update on nuclear markets & developments ahead in FY25

Uranium was one bright spot at the start of 2024, standing out against otherwise glum markets that defined 2023.
Sovereign's Kasiya project gains momentum, as Rio increases investment by 19.76% Sovereign Metals Ltd has seen a boost to its Kasiya rutile graphite project in Malawi, as Rio Tinto increases its interest in the company.
Sun Silver to kick off drilling next week at 292Moz Maverick Springs silver-gold project  The company has locked in a drilling contractor to fire up a Reverse Circulation (RC) drill rig at Maverick starting on 8th of July US time. 
Ark Mines inks 1.5Bt Exploration Target for Sandy Mitchell REE play including NdPr; PFS due in Q4 Ark Mines has published an Exploration Target for its Sandy Mitchell REE project of up to 1.5B tonnes @ up to 1490ppm monazite equivalent
Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring Sun Silver executive director Gerard O'Donovan discusses a 6,216 grams Fort Intercept at the Maverick Spring Silver Project from historical data and drill assessments.

Featured News

EX1 Tryptamine Therapeutics completes maiden dosing of IV psilocin – a global first
right-arrow Created with Sketch.
NEWS Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker
right-arrow Created with Sketch.
NEWS Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom
right-arrow Created with Sketch.
LRV Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%
right-arrow Created with Sketch.
AHK Ark Mines defines significant exploration target at Sandy Mitchell rare earths project
right-arrow Created with Sketch.
NEWS Has uranium run out of steam? An update on nuclear markets & developments ahead in FY25
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.